Buy 5-MeO-MiPT 15mg Pellets

Product Overview

5-MeO-MiPT 15mg Pellets offer a unitized solid form of 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT), a synthetic tryptamine of interest in advanced analytical and non-clinical research. By supplying the compound in a fixed-quantity pellet format, this product is designed to support reproducibility, streamlined documentation, and consistent handling across repeated experiments.

As a brandless research chemical with a defined purity of ≥98%, 5-MeO-MiPT 15mg Pellets are positioned for laboratories that require traceable, high-grade small-molecule inputs rather than consumer or clinical products. All handling and experimentation are intended to occur exclusively within professional laboratory settings under appropriate institutional oversight, without any implication of suitability for human or veterinary exposure. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Chemical Identity & Classification

5-MeO-MiPT (5-methoxy-N-methyl-N-isopropyltryptamine) is a substituted indole-based tryptamine characterized by a methoxy group at the 5-position of the indole ring and an N-methyl-N-isopropyl substitution on the ethylamine side chain. This structure places 5-MeO-MiPT within the class of synthetic 5-methoxy tryptamines that are frequently examined in analytical, forensic, and toxicological research.

Core identifiers for the base compound include:

• Preferred name: 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT)

• CAS number: 96096-55-8

• Molecular formula: C15H22N2O

• Molecular weight: approx. 246.4 g/mol

• Representative synonyms: 5-methoxy MiPT; 5-MeO MiPT; N-isopropyl-N-methyl-5-methoxytryptamine; 5-methoxy-N-methyl-N-isopropyltryptamine.

Within research, 5-MeO-MiPT is typically classified as:

• A synthetic tryptamine research chemical and analytical reference material.

• A small-molecule indole derivative used for non-clinical investigations, method development, and characterization studies under controlled conditions.

Chemical & Physical Characteristics

In laboratory preparations, 5-MeO-MiPT is commonly encountered as a crystalline or microcrystalline solid, with technical product information describing it as a crystalline tryptamine derivative. When formulated as 15mg pellets, the compound is integrated into discrete solid units designed to maintain structural integrity under typical handling and storage conditions.

The presence of the indole core, methoxy substitution, and tertiary amine side chain influences solubility and stability characteristics, with reference data indicating that 5-MeO-MiPT is supplied as a crystalline solid with a purity specification of ≥98% and long-term stability at appropriately low temperatures. Like many indolic compounds, sensitivity to light, oxygen, and elevated temperatures can be relevant, and researchers generally minimize unnecessary exposure to preserve chemical integrity.

Pelletized forms are engineered to deliver consistent mass per unit, which supports accurate documentation, gravimetric calculations, and recurrent use in standardized protocols. Lot-specific details such as exact appearance, any color notes, and spectral or chromatographic parameters are typically provided in the associated certificate of analysis (COA) or product information sheet.

Purity & Analytical Verification

5-MeO-MiPT 15mg Pellets are produced from material meeting or exceeding a ≥98% purity specification, aligned with high-grade research and reference-chemical standards. This purity level is suitable for advanced analytical workflows where even low-level impurities can affect chromatographic separation, spectral interpretation, quantitation, or comparative profiling.

Analytical verification of 5-MeO-MiPT identity and purity commonly involves a multi-technique approach, including high-performance liquid chromatography (HPLC), mass spectrometry (LC‑MS), nuclear magnetic resonance (NMR), and, in some technical documents, UV/Vis spectrophotometry with characteristic absorbance maxima. These methods provide complementary confirmation of structure, impurity profile, and conformity with specification limits for each batch. A batch-specific COA summarizing key test methods, assay values, and relevant parameters (such as purity, storage conditions, and stability) is typically available to qualified end users for QA documentation and internal review.

Quality Control & Batch Integrity

Each production lot of 5-MeO-MiPT 15mg Pellets is manufactured under batch-controlled conditions, with a unique lot or batch identifier assigned to support full traceability from synthesis through packaging. This traceability enables laboratories to link the physical product they receive to specific analytical data, SDS documentation, and any relevant technical notes.

Quality control procedures for research chemicals generally encompass verification of chemical identity, purity, appearance, and pellet integrity, as well as checks on label accuracy and packaging condition. Internal or cross-validated analytical methods may be employed to ensure consistent performance and to confirm that each batch falls within established specifications. Maintaining version-controlled analytical methods and clearly documented QC workflows helps end users integrate the product into regulated or audit-sensitive environments.

Safety, Handling & Laboratory Precautions

5-MeO-MiPT 15mg Pellets are intended exclusively for use by trained, qualified personnel working within appropriately equipped laboratory settings. Standard good laboratory practices (GLP) should be observed at all times, including the use of suitable personal protective equipment such as chemical-resistant gloves, protective eyewear, and laboratory coats, and, where policies require, work within fume hoods or other containment systems.

Users must consult the substance-specific safety data sheet (SDS/MSDS) for detailed information on hazard classification, potential exposure routes, recommended handling measures, spill procedures, and disposal guidance. Laboratory teams should avoid generating unnecessary dust or particulates from pellet handling, prevent uncontrolled release to the environment, and dispose of waste in accordance with institutional protocols and applicable regulations. No advice is provided or implied regarding dosing, administration, or any form of clinical or personal use; all activities must remain strictly within non-clinical research contexts.

Packaging, Labeling & Storage

5-MeO-MiPT 15mg Pellets are supplied in research-grade containers designed to protect pellet integrity and minimize exposure to environmental factors during storage and transport. Containers are typically sealed and may employ tamper-evident features, allowing end users to verify that the material has not been opened or altered prior to receipt.

Labels generally display the product designation, chemical name, CAS number, lot or batch number, and key hazard or precautionary statements consistent with regulatory expectations for laboratory chemicals. Technical literature for 5-MeO-MiPT recommends storage at reduced temperatures (commonly around −20 °C), in a tightly closed container, protected from light and moisture, to maximize stability over time. Laboratories should follow the storage conditions and shelf-life guidance defined in the SDS and COA, and ensure access is restricted to appropriately authorized personnel.

Intended Research Use & Market Positioning

5-MeO-MiPT 15mg Pellets are positioned strictly as a research-grade tryptamine preparation for professional, non-clinical use. Application areas may include analytical chemistry, forensic toxicology, neurochemistry, psychopharmacology, and method development where this compound is legally permitted and appropriate institutional approvals are in place.

The unit-dose pellet format caters to laboratories prioritizing reproducible unit quantities, simplified documentation, and minimized weighing variability compared with bulk powders. The product is not designed, advertised, or approved for human or veterinary use and carries no claims regarding psychological, therapeutic, or performance outcomes. End users are expected to understand and comply with any scheduling, licensing, or handling restrictions that may apply to 5-MeO-MiPT in their jurisdiction.

Ordering, Availability & Fulfillment

5-MeO-MiPT 15mg Pellets are intended for purchase by verified research customers via secure ordering channels compatible with institutional procurement processes. Order documentation typically includes clear product names, chemical identifiers, and lot numbers to support precise internal inventory management and record keeping.

Availability can be influenced by stock levels, production scheduling, and regional regulatory controls on tryptamine-class research chemicals. Shipments are generally prepared using discreet, robust outer packaging, with tracked delivery options where available, supporting chain-of-custody documentation and reliable delivery to laboratory addresses. Customer support teams can assist with documentation access (COAs, SDS files) and respond to pre‑purchase questions within the bounds of non-clinical, research-only guidance and applicable regulatory constraints.

Legal & Regulatory Disclaimer

This product is provided strictly as a research chemical for use in laboratory environments by qualified professionals operating under appropriate institutional oversight and legal authorization. It is not manufactured, approved, or intended for human or veterinary use and must not be used for clinical, diagnostic, therapeutic, or consumptive purposes in any form.

Responsibility for compliance with all applicable local, national, and international laws—including but not limited to scheduling, licensing, import/export, and controlled-substance regulations relating to 5-MeO-MiPT—rests solely with the purchaser and end user. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.